Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia
Abstract
Authors
D. Rosselli J.D. Rueda S. Wolowacz J. Brockbank S. Abeysinghe